Table: q1_q4_2019_prescription_drugs_wac_increases , manufacturer_name like L*

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  *

oshpd_id manufacturer_name date_reported ndc_number drug_product_description wac_effective_date wac_increase_amount wac_after_increase patent_expiration_date drug_source_type unit_sales_volume_in_us unit_sales_volume_non_public_indicator cost_increase_factors cost_increase_factors_non_public_indicator change_improvement_description change_improvement_non_public_indicator acquisition_date company_acquired_from acquisition_price acquisition_price_non_public_indicator acquisition_price_comment wac_at_acquisition wac_year_prior_to_acquisition year_drug_introduced_to_market wac_at_intro_to_market supporting_documents general_comments
Rx0000083 Laboratoire HRA Pharma 03/31/2019 76336008060 Antineoplastic 03/01/2019 359.05 839.00 None Single Source Drug None 1 None 1 None 1 03/16/2018 Bristol Myers Squibb None 1 No comment 479.95 None 1970 None None Column 6: Patent(s) expired. Product FDA approved 1970. Column 21: WAC at Intro to Market unknown. Introducted to U.S. market in 1970.
Rx0000083 Laboratoire HRA Pharma 09/30/2019 76336008060 Lysodren (mitotane) 100 mg tablets 07/01/2019 359.05 839.00 None Single Source Drug None 1 None 1 None 1 03/14/2018 Bristol Myers Squibb None 1 None 479.95 479.95 1970 157.44 None The exact year of BMS's Lysodren introduction is not known. Lysodren was FDA approved in 1970.
Rx0000083 Laboratoire HRA Pharma 06/30/2019 76336045518 Metopirone (metryapone) 250 mg capsules 04/09/2019 34.59 383.95 01/01/1981 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None HRA Pharma acquired Metopirone from Novartis in 2011 (exact date unknown).
Rx0000083 Laboratoire HRA Pharma 09/30/2019 76336045518 Metopirone (metryapone) 250 mg capsules 07/01/2019 34.56 383.95 01/01/1981 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None HRA Pharma acquired Metopirone from Novartis in 2011 (exact date unknown).
Rx0000089 Lannett Company, Inc. 03/31/2019 54838052340 Fluoxetine Oral Solution 20mg/5ml 01/11/2019 60.00 69.00 None Non-innovator Multiple Source Drug None 1 New serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. None n/a None None None None None None None None None None None No other price increases over that last five years other than the last one in 1/11/2019
Rx0000089 Lannett Company, Inc. 03/31/2019 54838050115 Haloperidol Oral Solution 2mg/ml 01/11/2019 14.87 20.86 None Non-innovator Multiple Source Drug None 1 Product API cost increases, new serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. None n/a None None None None None None None None None None None No other price increases over that last five years other than the last one in 1/11/2019
Rx0000089 Lannett Company, Inc. 03/31/2019 54838050140 Haloperidol Oral Solution 2mg/ml 01/11/2019 19.33 28.32 None Non-innovator Multiple Source Drug None 1 Product API cost increases, new serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. None n/a None None None None None None None None None None None No other price increases over that last five years other than the last one in 1/11/2019
Rx0000089 Lannett Company, Inc. 03/31/2019 54838055080 Ranitidine Syrup 15mg/ml 01/11/2019 57.00 75.00 None Non-innovator Multiple Source Drug None 1 New serialization/software costs, production line enhancements were factors in the price increase. Continued supply of market demand not sustainable without a price adjustment. None n/a None None None None None None None None None None None No other price increases over that last five years other than the last one in 1/11/2019
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994001104 Definity® Vial for (Perflutren Lipid Microsphere) Injectable Solution 01/01/2019 91.99 1011.92 03/16/2037 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994001116 Definity® Vial for (Perflutren Lipid Microsphere) Injectable Solution 01/01/2019 367.97 4047.67 03/16/2037 Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012106 Gallium-67 (Gallium Citrate Ga67 Injection) 01/01/2019 72.10 793.13 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012108 Gallium-67 (Gallium Citrate Ga67 Injection) 01/01/2019 96.13 1057.48 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012113 Gallium-67 (Gallium Citrate Ga67 Injection) 01/01/2019 144.19 1586.12 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012119 Gallium-67 (Gallium Citrate Ga67 Injection) 01/01/2019 216.30 2379.25 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009101 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 320.61 6735.05 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009103 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 374.70 7868.63 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009104 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 404.60 8496.69 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009105 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 435.65 9148.64 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009106 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 492.06 10333.31 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009107 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 576.47 12105.91 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009109 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 701.50 14731.49 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009110 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 824.78 17320.35 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009111 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 1014.48 21304.05 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009112 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 1247.81 26203.96 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009136 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 206.40 4334.38 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009173 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 260.42 5468.91 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009192 LEU TechneLite® (Technetium Tc99m Generator) 01/01/2019 286.29 6012.16 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994000602 NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) 01/01/2019 538.14 5919.57 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994001601 QUADRAMET® (Samarium Sm 153 Lexidronam Injection) 01/01/2019 1383.42 15217.64 None Single Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009001 TechneLite® (Technetium Tc99m Generator) 01/01/2019 259.41 5447.56 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009003 TechneLite® (Technetium Tc99m Generator) 01/01/2019 303.06 6364.35 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009004 TechneLite® (Technetium Tc99m Generator) 01/01/2019 327.25 6872.33 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009005 TechneLite® (Technetium Tc99m Generator) 01/01/2019 352.36 7399.66 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009006 TechneLite® (Technetium Tc99m Generator) 01/01/2019 397.99 8357.82 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009007 TechneLite® (Technetium Tc99m Generator) 01/01/2019 466.27 9791.55 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009009 TechneLite® (Technetium Tc99m Generator) 01/01/2019 567.39 11915.18 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009010 TechneLite® (Technetium Tc99m Generator) 01/01/2019 667.10 14009.11 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009011 TechneLite® (Technetium Tc99m Generator) 01/01/2019 820.53 17231.22 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009012 TechneLite® (Technetium Tc99m Generator) 01/01/2019 1009.26 21194.36 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009036 TechneLite® (Technetium Tc99m Generator) 01/01/2019 166.94 3505.77 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009073 TechneLite® (Technetium Tc99m Generator) 01/01/2019 210.64 4423.37 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994009092 TechneLite® (Technetium Tc99m Generator) 01/01/2019 231.56 4862.76 07/01/2029 Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012711 Xenon-133 (Xenon Xe 133 Gas) 01/01/2019 25.63 281.89 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012715 Xenon-133 (Xenon Xe 133 Gas) 01/01/2019 95.32 1048.56 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012821 Xenon-133 (Xenon Xe 133 Gas) 01/01/2019 41.55 457.09 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000009 Lantheus Medical Imaging, Inc. 03/31/2019 11994012825 Xenon-133 (Xenon Xe 133 Gas) 01/01/2019 194.13 2135.40 None Innovator Multiple Source Drug None 1 None 1 None 1 None None None None None None None None None None None
Rx0000196 Lexicon Pharmaceuticals 09/30/2019 70183012584 XERMELO Telotristat Ethyl 250 mg 84 tablets 07/02/2019 1089.00 6253.00 12/11/2027 Single Source Drug None 1 None 1 no change None None None None None None None None None None None Product developed internally. No acquisition.
Rx0000025 Lundbeck LLC 03/31/2019 67386082019 Northera 100mg. 90 Capsules 01/07/2019 233.70 2594.26 02/18/2021 Single Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None 06/23/2014 "Chelsea Therapeutics International, Ltd." None 1 "The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." 1409.00 None 2014 1409.00 None WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition.
Rx0000025 Lundbeck LLC 03/31/2019 67386082119 Northera 200mg. 90 Capsules 01/07/2019 467.39 5188.51 02/18/2021 Single Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None 06/23/2014 "Chelsea Therapeutics International, Ltd." None 1 "The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." 2818.00 None 2014 2818.00 None WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition.
Rx0000025 Lundbeck LLC 03/31/2019 67386082219 Northera 300mg. 90 Capsules 01/07/2019 701.09 7782.78 02/18/2021 Single Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None 06/23/2014 "Chelsea Therapeutics International, Ltd." None 1 "The Acquisition Price was left blank since Lundbeck acquired the rights to Northera through the purchase of Chelsea Therapeutics International, Ltd. for USD 6.44 per share in cash and non-transferable contingent value rights that may pay up to an additional USD 1.5 per share upon achievement of certain sales milestones, in each case without interest and subject to any required withholding of taxes." 4227.00 None 2014 4227.00 None WAC at acquisition is the same as WAC at introduction given that Northera did not launch until after acquisition.
Rx0000025 Lundbeck LLC 03/31/2019 67386031401 Onfi 10mg. 100 Tablets 01/07/2019 181.22 2011.74 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386031501 Onfi 20mg. 100 Tablets 01/07/2019 362.44 4023.44 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386031321 Onfi Oral Suspension 2.5mg/mL 120mL Bottle 01/07/2019 95.22 1056.99 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386011101 Sabril 500mg. 100 Tablets 01/07/2019 1316.25 14611.73 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386021165 Sabril 500mg. 50 Packets 500mg. each 01/07/2019 658.13 7305.87 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386042101 Xenazine 12.5mg. 112 Tablets 01/07/2019 1270.09 14099.29 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None
Rx0000025 Lundbeck LLC 03/31/2019 67386042201 Xenazine 25.0mg. 112 Tablets 01/07/2019 2540.18 28198.58 None Innovator Multiple Source Drug None 1 "Our industry is different from almost any other, in that the price for a product often increases over time. That may seem counterintuitive until you realize that drugs are different from cars, computers or clothing. Once we bring a product to patients, that begins another series of investments so we can follow the progress and safety of patients taking the drug, develop better formulations that benefit the patient community, investigate its application to other indications and more. Price increases are what pay for those investments across our industry." None This WAC increase is not necessitated by a change or improvement in the prescription drug. None None None None None None None None None None None None